Clinical Trial Update: Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing vinorelbine plus apatinib to vinorelbine alone in advanced triple-negative breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Apatinib (apatinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Fudan University | Conditions: Advanced Triple-Negative Breast Cancer | Phase 2 | Status: COMPLETED